# Safety and Efficacy of Klotho and Follistatin Gene Therapy

> **NCT07285629** · EARLY_PHASE1 · RECRUITING · sponsor: **Minicircle** · enrollment: 30 (estimated)

## Conditions studied

- Healthy Adults

## Interventions

- **GENETIC:** Follistatin and klotho gene therapy

## Key facts

- **NCT ID:** NCT07285629
- **Lead sponsor:** Minicircle
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-16
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07285629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07285629, "Safety and Efficacy of Klotho and Follistatin Gene Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07285629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*